May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Pembrolizumab vs. Observation in Muscle-Invasive Urothelial Carcinoma
Oct 7, 2024, 15:53

Pembrolizumab vs. Observation in Muscle-Invasive Urothelial Carcinoma

Tres Uramigas shared on X:

“Sure! Here’s the post without the usernames:

AMBASSADOR: Phase III Ca Urothelial with muscle invasion post-cystectomy pembrolizumab 1 vs observation in New England Journal of Medicine, Andrea Apolo, Petros Grivas.

  • Disease-Free Survival (DFS) benefit
  •  Independent of PD-L1 and nodal status
  • Metastatic recurrences frequency in the control arm.”

Pembrolizumab vs. Observation in Muscle-Invasive Urothelial Carcinoma
Source: Tres Uramigas/X